Eyenovia Sees the Bigger Picture With New Licensing Deal
Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.
All Work
Chris Lange
5 Speculative Biotechs With 50% to 300% Implied Upside
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Nikola Takes Its First Steps Toward Actual Revenue
Electric truck maker Nikola has announced a partnership with Republic Services to develop and purchase 2,500 electric waste and recycling collection trucks.
Royal Caribbean Earnings: When Bad Is Actually Good for Investors
Royal Caribbean Cruises reported mixed quarterly results before the markets opened on Monday, but shares traded higher.
Good News for C Diff Sufferers and Seres Therapeutics Investors
Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile infection study.
Applied Materials, Barrick, Cisco, DraftKings and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Cisco Systems, Nio, Occidental Petroleum and some of the other most anticipated quarterly reports due this week.
Investors Cheer AnPac Bio’s Coronavirus Developments
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Why Conduent Is Friday’s Big Earnings Winner
Conduent stock rallied after the company reported better than expected second-quarter financial results late Thursday.
Is Groupon Back After Explosive Q2?
Groupon stock rallied Friday morning after the online marketplace provider reported better than expected second-quarter financial results late Thursday.
Is Uber Now a Delivery Company After This Quarter?
Ride-sharing giant Uber reported second-quarter financial results after markets closed Thursday. The company posted a net loss of $1.02 per share and $2.24 billion in revenue compared with consensus estimates t for a net…
Rocket Mortgage and Quicken Loans Parent Quietly Enters the Market
Rocket Companies, parent of Rocket Mortgage and Quicken Loans, quietly entered the market on Thursday in its initial public offering.
Denali Therapeutics Takes Next Big Step in Treating Parkinson’s
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
How Plug Power’s Rosy Outlook and Acquisitions Played Into an All-Around Solid Q2
Plug Power released a better than expected second-quarter earnings report before the markets opened on Thursday, and shares shot up afterward.
Etsy Earnings: When Incredible Isn’t Good Enough
Etsy shares sank early Thursday even though it reported better than expected second-quarter financial results after the markets closed on Wednesday.
Why Roku’s Q2 Report Is So Great
Streaming video firm Roku reported a second-quarter net loss of $0.35 per share and $356 million in revenue compared to consensus estimates calling for a net loss of $0.50 per share and $315 million…
Rackspace’s IPO Is Severely Underwhelming
End-to-end multicloud technology services company Rackspace Technology entered the market with a whimper.
Novavax Bulls Keep Charging as More COVID-19 Results Come Out
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Key Apple Analyst Downgrade Not Just About Stock Price
Many see Apple stock going nowhere but up. See why Wamsi Mohan at BofA Securities has downgraded the stock but increased the price target.
Which Segment Dragged on Beyond Meat in Q2?
Beyond Meat reported its most recent quarterly results after the markets closed on Tuesday, and shares retreated early Wednesday.
5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be inexpensive…